AstraZeneca Unloads Four NDAs to ANI Pharmaceuticals in $46.5M Deal
ANI Phamaceuticals funded the acquisitions through a combination of cash and debt.
Source: BioSpace
ANI Phamaceuticals funded the acquisitions through a combination of cash and debt.
Source: BioSpace